Replies to post #318915 on Elite Pharmaceuticals Inc (ELTP)

[Chasing]

Yes, doubling and tripling revenues is always a terrible thing.

However, that doubling and tripling doesn't even include the better money maker coming. On top of that, doubling and tripling revenue will allow us to pay for the new hurdle the FDA came up with for SequestOx.

Even if the revenues double or triple, as has been posited here, the revenues will still be TOO LOW to matter.

Ceo's everywhere cringe at the thought of doubling and tripling revenues.